{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-23-000009","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2023-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.900986+00:00","generated_at":"2026-06-13T15:49:40.247391+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Kewaunee Scientific posts Q4 profit of $0.34/share; FY revenue up 30% to $219.5M","bullets":["Q4 net earnings $1,005,000 ($0.34 diluted EPS) vs net loss of $362,000 ($0.13 loss) in prior year.","Q4 sales $53,986,000, up 8.6% YoY; International segment sales surged 57.3% to $18,863,000.","Full fiscal year 2023 net earnings $738,000 ($0.25 EPS) vs net loss $6,126,000 ($2.20 loss); sales up 30% to $219,494,000.","EBITDA for FY2023 improved to $7,517,000 from $394,000; domestic segment returned to profit.","Backlog at April 30, 2023 was $147.9 million, down from $173.9 million a year ago; cash increased to $13.8 million from $6.9 million."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-23-000009","json":"https://secwatch.observer/filing/0000055529-23-000009.json","markdown":"https://secwatch.observer/filing/0000055529-23-000009.md","text":"https://secwatch.observer/filing/0000055529-23-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552923000009/0000055529-23-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552923000009/kequ-20230628.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T15:49:40.247391+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3889cf23dc9b5ef7294a1e8ab068f3fb24e59104","claim":"KEWAUNEE SCIENTIFIC CORP /DE/ reported financial results for the fourth quarter and fiscal year ended April 30, 2023.","evidence_excerpt":"On June 28, 2023, Kewaunee Scientific Corporation issued a press release announcing its financial results for the fourth quarter and fiscal year ended April 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/55529/000005552923000009/0000055529-23-000009-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and fiscal year ended April 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}